Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO-Congress-2020-1000x250

Immuno-Oncology

Translating Immuno-Oncology Biomarkers into Clinical Practice

05-Translating-Immuno-Oncology-Biomarkers-into-Clinical-Practice-MSD-Thumb

On Demand Session
View the satellite invitation

The Future Is Now: Transforming Management of GI Cancers with Immuno-Oncology

01-The-Future-is-Now-Transforming-Management-of-GI-Cancers-with-Immuno-Oncology-BMS-Thumb

On Demand Session
View the satellite invitation

Antibody Drug Conjugates (ADCs): Advancements in The Treatment of Solid Tumours

08-Antibody-Drug-Conjugates-ADCs-Advancements-in-The-Treatment-of-Solid-Tumours-Thumb

On Demand Session
View the satellite invitation

Exploring the Current and Evolving Landscape in Thoracic Cancers

16-Melanoma-In-2020-Reflect-Reset-and-Continue-BMS-Thumb

On Demand Session
View the satellite invitation

Immune Checkpoint Blockade in Non-Melanoma Skin Cancer

22-Immune-Checkpoint-Blockade-in-Non-Melanoma-Skin-Cancer-SANOFI-GENZYME-Thumb

On Demand Session
View the satellite invitation

Update on The Evolving Landscape for Endometrial Cancer Treatment with Immunotherapy 

23-Update-on-the-Evolving-Landscape-for-Endometrial-Cancer-GSK-Thumb

On Demand Session
View the satellite invitation

Optimising the Patients’ CAR T-Cell Journey

28-Optimising-the-Patients’-CAR-T-Cell-Journey-KITE-Thumb

On Demand Session
View the satellite invitation

Multiple Immunotherapeutic Options: Clinical Decision Making in Advanced Renal Cell Carcinoma and Urothelial Carcinoma

47--Multiple-Immunotherapeutic-Options-MSD-Thumb

On Demand Session
View the satellite invitation

Reshaping Treatment Paradigms for GU Cancer Patients: Perspectives on PI3K/AKT Inhibitors in mCRPC and Immunotherapy inl Cance Urotheliar

55-Reshaping-Treatment-Paradigms-for-GU-Cancer-Patients-ROCHE-Thumb

On Demand Session
View the satellite invitation

PD1 Inhibitors on the Horizon for NSCLC: Current Knowledge, Future Possibilities

57-PD1-Inhibitors-on-the-Horizon-for-NSCLC-Current-Knowledge-TOUCHIME-Thumb

On Demand Session
View the satellite invitation

Please note: The European Society for Medical Oncology (ESMO) does not endorse any of the companies, or their products/services, that have sponsored these links.

View the complete ESMO Virtual Congress 2020 Industry Sponsored Satellite Symposia Programme

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings